BioLife Solutions, Inc. (BLFS) financial statements (2021 and earlier)
Company profile
| Business Address |
3303 MONTE VILLA PARKWAY BOTHELL, WA 98021 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 90 | 94 | 30 | 6 | 6 | 21 | 20 | ||
| Cash and cash equivalents | 90 | 94 | 30 | 6 | 6 | 21 | 20 | ||
| Restricted cash and investments | 0 | 15 | |||||||
| Receivables | 8 | 6 | 4 | 8 | 5 | 4 | 4 | ||
| Inventory, net of allowances, customer advances and progress billings | 12 | 11 | 11 | 11 | 11 | 6 | 5 | ||
| Inventory | 12 | 11 | 11 | 11 | 11 | 6 | 5 | ||
| Other undisclosed current assets | 5 | 2 | 1 | 1 | 1 | 1 | 0 | ||
| Total current assets: | 115 | 128 | 46 | 26 | 24 | 32 | 29 | ||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset | 0 | ||||||||
| Operating lease, right-of-use asset | 10 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Property, plant and equipment | 10 | 5 | 5 | 5 | 6 | 2 | 1 | ||
| Long-term investments and receivables | 0 | 0 | 0 | 1 | 6 | ||||
| Long-term investments | 0 | 0 | 0 | 1 | 6 | ||||
| Intangible assets, net (including goodwill) | 89 | 53 | 54 | 55 | 56 | 45 | 14 | ||
| Goodwill | 58 | 34 | 34 | 34 | 34 | 28 | 10 | ||
| Intangible assets, net (excluding goodwill) | 31 | 20 | 21 | 21 | 22 | 16 | 4 | ||
| Deposits noncurrent assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other undisclosed noncurrent assets | 11 | 9 | 7 | 7 | 6 | 3 | |||
| Total noncurrent assets: | 120 | 68 | 68 | 69 | 69 | 52 | 23 | ||
| TOTAL ASSETS: | 235 | 196 | 114 | 95 | 93 | 84 | 52 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 4 | 3 | 3 | 3 | 3 | 4 | 2 | ||
| Accounts payable | 4 | 2 | 3 | 4 | 3 | 2 | 1 | ||
| Accrued liabilities | 0 | 3 | 3 | 3 | 3 | 1 | 0 | ||
| Employee-related liabilities | 2 | 1 | |||||||
| Taxes payable | 0 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | (2) | (3) | (4) | (3) | |||||
| Deferred revenue | 1 | ||||||||
| Debt | 1 | 1 | 1 | ||||||
| Deferred compensation liability | 3 | ||||||||
| Derivative instruments and hedges, liabilities | 3 | 2 | 1 | 18 | |||||
| Business combination, contingent consideration, liability | 3 | 0 | 0 | 0 | 0 | ||||
| Other liabilities | 0 | ||||||||
| Other undisclosed current liabilities | 1 | 3 | 4 | 4 | 4 | ||||
| Total current liabilities: | 16 | 8 | 7 | 25 | 8 | 5 | 3 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 9 | 0 | 0 | 0 | 1 | 1 | 1 | ||
| Finance lease, liability | 0 | 0 | 0 | ||||||
| Operating lease, liability | 9 | 0 | 0 | 0 | 1 | 1 | 1 | ||
| Liabilities, other than long-term debt | 5 | 1 | 1 | 1 | 41 | 2 | 2 | ||
| Other liabilities | 1 | 0 | 0 | 0 | 0 | 0 | |||
| Business combination, contingent consideration, liability | 5 | 0 | 0 | 1 | 2 | 2 | 2 | ||
| Derivative instruments and hedges, liabilities | 40 | ||||||||
| Total noncurrent liabilities: | 14 | 1 | 1 | 2 | 42 | 2 | 2 | ||
| Total liabilities: | 30 | 9 | 8 | 27 | 49 | 7 | 5 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 205 | 187 | 106 | 68 | 43 | 77 | 46 | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Additional paid in capital | 303 | 282 | 200 | 145 | 143 | 137 | 116 | ||
| Accumulated deficit | (97) | (95) | (94) | (78) | (100) | (60) | (70) | ||
| Total stockholders' equity: | 205 | 187 | 106 | 68 | 43 | 77 | 46 | ||
| TOTAL LIABILITIES AND EQUITY: | 235 | 196 | 114 | 95 | 93 | 84 | 52 | ||
Income statement (P&L) ($ in millions)
| 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 15 | 11 | 10 | 12 | 8 | 7 | 7 | |
| Cost of revenue | (8) | (5) | (4) | (5) | (3) | (2) | (2) | |
| Cost of goods and services sold | (5) | (4) | (5) | (2) | (2) | |||
| Gross profit: | 6 | 6 | 5 | 8 | 5 | 5 | 5 | |
| Operating expenses | (10) | (8) | (7) | (7) | (6) | (5) | (4) | |
| Other undisclosed operating income (loss) | (2) | 0 | 1 | 0 | ||||
| Operating income (loss): | (5) | (1) | 0 | 0 | (1) | (1) | 1 | |
| Nonoperating income (expense) | (1) | 0 | (16) | 22 | (13) | 10 | (0) | |
| Investment income, nonoperating | 1 | 0 | 0 | |||||
| Interest and debt expense | (0) | (0) | (0) | (0) | ||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 0 | |||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (5) | (1) | (16) | 22 | (14) | 9 | 1 | |
| Other undisclosed income (loss) from continuing operations before income taxes | (0) | 0 | 0 | 0 | 0 | |||
| Income (loss) from continuing operations before income taxes: | (5) | (1) | (16) | 22 | (14) | 9 | 1 | |
| Other undisclosed income from continuing operations | 3 | 2 | ||||||
| Net income (loss) attributable to parent: | (2) | (1) | (16) | 22 | (12) | 9 | 1 | |
| Other undisclosed net income (loss) available to common stockholders, basic | 0 | (4) | ||||||
| Net income (loss) available to common stockholders, basic: | (2) | (1) | (16) | 18 | (12) | 9 | 1 | |
| Other undisclosed net income (loss) available to common stockholders, diluted | 1 | (19) | ||||||
| Net income (loss) available to common stockholders, diluted: | (1) | (1) | (16) | (0) | (12) | 9 | 1 | |
Comprehensive Income ($ in millions)
| 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (2) | (1) | (16) | 22 | (12) | 9 | 1 | |
| Comprehensive income (loss), net of tax, attributable to parent: | (2) | (1) | (16) | 22 | (12) | 9 | 1 | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.